PRESS RELEASE
News
-
-
PRESS RELEASE
OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
OSE Immunotherapeutics, Inserm Transfert, and Nantes University form a strategic partnership to advance immunotherapy for oncology, inflammation, and autoimmunity. The collaboration combines academic research and industrial expertise -
-
-
-
-
PRESS RELEASE
EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
EssilorLuxottica's Essilor Stellest lens, the first FDA market authorized spectacle lens in the U.S., clinically proven to slow myopia progression in children, with 71% effectiveness over 2 years -
PRESS RELEASE
EssilorLuxottica: Essilor Stellest est le tout premier verre optique à recevoir de la FDA une autorisation de mise sur le marché aux États-Unis
EssilorLuxottica obtient l'autorisation de la FDA pour le verre Essilor Stellest, unique pour ralentir la myopie chez les enfants. Étude clinique démontre un ralentissement de 71% sur 2 ans -
PRESS RELEASE
Northern Dynasty: Fourth Tranche of $12 million Royalty Investment Received, Update on Government Discussions and Court Filings
Northern Dynasty Minerals Ltd. announces receipt of $12 million payment as the fourth tranche of investment under the royalty agreement, maintaining a strong treasury position for project development -
PRESS RELEASE
Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel
Aelis Farma annonce la mise \u00e0 disposition du rapport financier semestriel 2025 et pr\u00e9sente ses avanc\u00e9es en innovation th\u00e9rapeutique avec les inhibiteurs sp\u00e9cifiques du r\u00e9cepteur CB1
